Undeclared Milk Alert: Better Bakehouse recall targets 7.05oz Donutful donuts sold nationwide in March 2026
The FDA warns consumers about potential allergic reactions to these specific mini donuts
We all crave the simple pleasure of a morning treat. The FDA is reminding us that safety is the most important ingredient in any recipe. The Better Bakehouse Snack Company recently issued a nationwide recall for a specific snack. It is the Donutful Chocolate Dipped Vanilla Cake Donuts. This recall came after officials noted an allergic reaction was reported. The issue stems from a mislabeling problem where milk was not clearly listed.
The details of this recall are specific and require a quick pantry check. The affected product consists of select lots made and distributed in March 2026. You will find them in a 7.05 oz carton containing five 1.41-ounce pouches. The UPC for this batch is 3 50041 39210 3. These 10 Mini Donuts were distributed to retailers across the country and also sold through Amazon.com. If you have a box from this time period, it is worth checking the back of the package.
We prefer the ordinary done well, which means we want our food to be predictable and safe. Undeclared milk can be a serious threat for those with severe sensitivities. The FDA warns that people with these allergies run the risk of life-threatening reactions. Fortunately, the individual who became ill has recovered. This news serves as a reminder to read labels carefully. The company emphasizes that consumer safety is their top priority.
The Better Bakehouse Snack Company is taking action. They are working with their contract manufacturer and retailers to remove any remaining affected product from the marketplace. If you see these specific donuts on the shelf, they are likely safe after this date. However, you should double check the batch number if you are unsure. A little bit of caution goes a long way when it comes to your health.
First reported by foxbusiness.com.
More in Health & Nutrition
- Long-term opioid use fails to alleviate chronic back pain, Northwestern University study suggests
Researchers identified distinct brain activity patterns and molecular markers that may guide future treatments for pain management and opioid tapering.
- Human tau seeds trigger disease-specific shapes in mouse brains, new study finds
Study in Nature shows that injectable human tau aggregates from Alzheimer’s and corticobasal degeneration template their 3D folds onto mouse tau, supporting the prion-like seeding model.
- Menopause Largely Missing from Electronic Health Records Despite Its Health Impact
study of nearly 240,000 women finds only 12% of electronic records include menopause status, even though over half reported being in transition.